Literature DB >> 29760259

Biotin interference: Underrecognized patient safety risk in laboratory testing.

Jessica L Gifford1, S M Hossein Sadrzadeh2, Christopher Naugler3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29760259      PMCID： PMC5951654     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  5 in total

1.  Biotin supplementation in MS clinically valuable but can alter multiple blood test results.

Authors:  Ursela Siddiqui; Emily Egnor; Jacob A Sloane
Journal:  Mult Scler       Date:  2016-12-07       Impact factor: 6.312

Review 2.  False biochemical diagnosis of hyperthyroidism in streptavidin-biotin-based immunoassays: the problem of biotin intake and related interferences.

Authors:  Marie-Liesse Piketty; Michel Polak; Isabelle Flechtner; Laura Gonzales-Briceño; Jean-Claude Souberbielle
Journal:  Clin Chem Lab Med       Date:  2017-05-01       Impact factor: 3.694

3.  High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference.

Authors:  Marie-Liesse Piketty; Dominique Prie; Frederic Sedel; Delphine Bernard; Claude Hercend; Philippe Chanson; Jean-Claude Souberbielle
Journal:  Clin Chem Lab Med       Date:  2017-05-01       Impact factor: 3.694

Review 4.  Factitious Graves' Disease Due to Biotin Immunoassay Interference-A Case and Review of the Literature.

Authors:  Marianne S Elston; Shekhar Sehgal; Stephen Du Toit; Tania Yarndley; John V Conaglen
Journal:  J Clin Endocrinol Metab       Date:  2016-06-30       Impact factor: 5.958

5.  MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study.

Authors:  Ayman Tourbah; Christine Lebrun-Frenay; Gilles Edan; Michel Clanet; Caroline Papeix; Sandra Vukusic; Jerome De Sèze; Marc Debouverie; Olivier Gout; Pierre Clavelou; Gilles Defer; David-Axel Laplaud; Thibault Moreau; Pierre Labauge; Bruno Brochet; Frédéric Sedel; Jean Pelletier
Journal:  Mult Scler       Date:  2016-09-01       Impact factor: 6.312
  5 in total
  3 in total

1.  Comparison of Biotin Interference in Second- and Third-Generation Roche Free Thyroxine Immunoassays.

Authors:  Jungim Choi; Seung Gyu Yun
Journal:  Ann Lab Med       Date:  2020-05       Impact factor: 3.464

2.  Biotin Interference in Point of Care HIV Immunoassay.

Authors:  Mohan Kumar Haleyur Giri Setty; Sherwin Lee; Julia Lathrop; Indira K Hewlett
Journal:  Biores Open Access       Date:  2020-11-24

3.  Selective quantification of the 22-kDa isoform of human growth hormone 1 in serum and plasma by immunocapture and LC-MS/MS.

Authors:  Bas Sleumer; Martijn van Faassen; Michel J Vos; Rainer Bischoff; Ido P Kema; Nico C van de Merbel
Journal:  Anal Bioanal Chem       Date:  2022-07-15       Impact factor: 4.478
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.